Cargando…

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study

Oxidative stress contributes to chronic obstructive pulmonary disease (COPD) exacerbations and antioxidants can decrease exacerbation rates, although we lack data about the effect of such drugs on exacerbation duration. The RESTORE (Reducing Exacerbations and Symptoms by Treatment with ORal Erdostei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Negro, Roberto W., Wedzicha, Jadwiga A., Iversen, Martin, Fontana, Giovanni, Page, Clive, Cicero, Arrigo F., Pozzi, Edoardo, Calverley, Peter M.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678897/ https://www.ncbi.nlm.nih.gov/pubmed/29025888 http://dx.doi.org/10.1183/13993003.00711-2017

Ejemplares similares

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
por: Calverley, Peter M A, et al.
Publicado: (2022)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Is gastro-oesophageal reflux associated with COPD exacerbations?
por: Wedzicha, Jadwiga A.
Publicado: (2013)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset [Corrigendum]
Publicado: (2022)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

COPD exacerbations: defining their cause and prevention
por: Wedzicha, Jadwiga A, et al.
Publicado: (2007)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent
por: Cazzola, Mario, et al.
Publicado: (2020)

The role of bronchodilator treatment in the prevention of exacerbations of COPD
por: Wedzicha, Jadwiga A., et al.
Publicado: (2012)

Roflumilast: a review of its use in the treatment of COPD
por: Wedzicha, Jadwiga A, et al.
Publicado: (2016)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD
por: Moretti, Maurizio, et al.
Publicado: (2015)

Exacerbation rate, health status and mortality in COPD – a review of potential interventions
por: Seemungal, Terence AR, et al.
Publicado: (2009)

The role of complement activation in COPD exacerbation recovery
por: Westwood, John-Paul, et al.
Publicado: (2016)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Exacerbations: Etiology and Pathophysiologic Mechanisms
por: Wedzicha, Jadwiga A.
Publicado: (2002)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Erdosteine Therapy for Renal Failure: Current Perspectives
por: Muthuraman, Arunachalam
Publicado: (2012)

Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD
por: Cazzola, Mario, et al.
Publicado: (2023)

Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations
por: Platé, Manuela, et al.
Publicado: (2014)

Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD
por: Wilkinson, Tom M.A., et al.
Publicado: (2006)

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine
por: Rogliani, Paola, et al.
Publicado: (2019)

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
por: Mackay, Alexander J., et al.
Publicado: (2020)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008)

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2008)

Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
por: Brill, Simon E, et al.
Publicado: (2014)

COPD discharge bundle and pulmonary rehabilitation referral and uptake following hospitalisation for acute exacerbation of COPD
por: Barker, Ruth E, et al.
Publicado: (2021)

Erdosteine ameliorates lung injury induced by transient aortic occlusion in rats
por: Kurtoglu, Tunay, et al.
Publicado: (2007)

Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
por: Ritchie, Andrew I., et al.
Publicado: (2020)

Effect of Aclidinium Bromide on Exacerbations in Patients with Moderate-to-Severe COPD: A Pooled Analysis of Five Phase III, Randomized, Placebo-Controlled Studies
por: Wedzicha, Jadwiga A., et al.
Publicado: (2016)

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
por: Calverley, Peter MA, et al.
Publicado: (2017)

Impact of the UK lockdown on people at risk of COPD
por: Donaldson, Gavin C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tjkto8liv85s3j618213muck4l